{"id":5872,"date":"2020-07-24T12:04:16","date_gmt":"2020-07-24T10:04:16","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2020\/07\/10_104270789.jpg"},"modified":"2021-03-04T08:19:10","modified_gmt":"2021-03-04T07:19:10","slug":"10_104270789-2","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/10_104270789-2\/","title":{"rendered":"10_104270789"},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-5872","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n